Advocating for Health Equity

Shaping a new era of global health investment, policy, planning and prevention

AVAC Meeting in NYC

Advocacy and activism have been a linchpin in the history of HIV treatment and prevention. The visionary work of passionate advocates has resulted in hard-fought global gains against HIV.

AVAC is part of a robust civil society movement helping to shape a new era of global health spending and planning related to HIV prevention. We mobilize to ensure programs, products and policies are evidence-based, inclusive and effective. With our partner network, we identify critical needs and develop strategic campaigns to advance HIV prevention, with a focus on ensuring a rich pipeline of options move through research and development, and rollout effectively to reach the communities who need them most.

Our advocacy takes place:

  • Where funders, policies and programs come together.
  • At the point of service delivery, where options from the pipeline must become choices in people’s lives. 
  • At Parliaments, State Houses, Ministries of Health, National legislatures, and international bodies,to press for global and country accountability.
  • In the hands of robust and sophisticated coalitions of African-led civil society organizations.

The Latest on Advocating for Health Equity

Article

Accelerating policy approval and uptake of the dual prevention pill in Zambia through early stakeholder engagement

The Dual Prevention Pill (DPP), a combination of PrEP and combined oral contraception (COC), offers a novel, female-controlled option for HIV and unintended pregnancy prevention. This article in AIDS Care, authored by AVAC Fellow Rhoda Msiska, AVAC staff members Kate Segal and Cindra Feuer, and Newton Donkola, demonstrates how early, multisectoral stakeholder engagement could accelerate DPP approval and adoption in Zambia.

Infographic

Potential Lenacapavir Supply, 2026-28

Lenacapavir has the potential to reach millions — and the momentum is building. Using the current oral PrEP market as a baseline, this graphic estimates what demand for LEN could look like through 2028 and shows how current donor commitments stack up against that opportunity.

Article

AVAC Comment Submission on the White House OMB Proposed Federal Financial Assistance Rule

As an advocate for scientific integrity, public health and evidence-based policymaking, AVAC strongly opposes the White House Office of Management and Budget’s proposed Regulation for Federal Financial Assistance. This document outlines AVAC’s key concerns with the proposal, which were submitted July 9, 2026.